Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 18, 2023 -- Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication, according to a study published online July 31 in The Journal of Infectious Diseases.
Noting that patients with chronic HCV do not respond to HBV vaccination as efficiently as the general population, Jesse G. Powell, from Hennepin Healthcare in Minneapolis, and colleagues examined whether revaccination after HCV treatment improves response. Previous HBV vaccine nonresponders were recruited for revaccination after HCV eradication.
Thirty-one of 34 enrolled patients underwent follow-up hepatitis B surface antibody (HBsAb) testing one month after vaccine series completion. The researchers found that 21 of the patients (67.7 percent) produced a reactive HBsAb, eight were nonreactive, and two had equivocal results (25.8 and 6.5 percent, respectively). No significant differences were seen in HBsAb reactivity according to age, sex, race, or presence of advanced fibrosis.
"This study has broad implications for public health in hepatitis-infected individuals," coauthor Jose Debes, M.D., Ph.D., from the University of Minnesota in Minneapolis, said in a statement. "It is known that the hepatitis B vaccine is not as effective in those with hepatitis C. What was not known until now is that after treating hepatitis C the hepatitis B vaccine seems to be more effective in this population. This is important as many of these individuals are still at risk for hepatitis B infection."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Preparedness for HPAI A(H5N1) Virus Varies Across Jurisdictions
TUESDAY, May 21, 2024 -- Variation is seen in preparedness and response to highly pathogenic avian influenza (HPAI) A(H5N1) viruses, according to a research letter published...
Hep C Infection Poses Global Public Health Threat to Reproductive-Age Women
WEDNESDAY, May 15, 2024 -- Both acute hepatitis C (AHC) and hepatitis C virus (HCV)-related cirrhosis incidence were up substantially globally from 1990 to 2019 in...
Chronic Hepatitis B Virus Is Undertreated
FRIDAY, May 3, 2024 -- Underassessment and undertreatment of chronic hepatitis B virus (HBV) is seen globally, according to a study published online May 1 in the Journal of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.